Projected Income Statement: Virbac

Forecast Balance Sheet: Virbac

Forecast Balance Sheet - Virbac
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 -73.8 -79.4 -52.4 169 173 122 44.7 -59
Change - -7.59% 34.01% 422.52% 2.37% -29.4% -63.36% -231.99%
Announcement Date 3/22/22 A 3/23/23 A 3/19/24 A 3/13/25 A 3/17/26 A - - -
1EUR in Million
Estimates

Cash Flow Forecast: Virbac

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 33.65 53.58 59.9 80.44 92.24 122.7 116.4 113.7
Change - 59.21% 11.8% 34.29% 14.67% 33.05% -5.15% -2.33%
Free Cash Flow (FCF) 1 96.25 45.41 58.74 123.8 106.8 88.43 121.6 149
Change - -52.82% 29.36% 110.73% -13.76% -17.16% 37.49% 22.59%
Announcement Date 3/22/22 A 3/23/23 A 3/19/24 A 3/13/25 A 3/17/26 A - - -
1EUR in Million
Estimates

Forecast Financial Ratios: Virbac

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 20.21% 18.37% 18.67% 20.25% 19.76% 20.5% 21.29% 22.01%
EBIT Margin (%) 15.87% 15.03% 14.83% 16.28% 15.68% 16.6% 17.23% 17.86%
EBT Margin (%) 14.95% 14.51% 13.97% 14.87% 14.85% 16.09% 17.32% 18.31%
Net margin (%) 10.64% 10.03% 9.73% 10.4% 10.3% 11.24% 11.78% 12.33%
FCF margin (%) 9.05% 3.73% 4.71% 8.86% 7.29% 5.72% 7.39% 8.61%
FCF / Net Income (%) 85.03% 37.22% 48.43% 85.2% 70.75% 50.85% 62.76% 69.83%

Profitability

        
ROA - 9.62% 8.7% 8.79% 8.02% 8.2% 8.2% 8.2%
ROE 16.82% 15.59% 13.94% 14.95% 13.92% 14.05% 13.64% 12.85%

Financial Health

        
Leverage (Debt/EBITDA) - - - 0.6x 0.6x 0.39x 0.13x -
Debt / Free cash flow - - - 1.36x 1.62x 1.38x 0.37x -

Capital Intensity

        
CAPEX / Current Assets (%) 3.16% 4.41% 4.8% 5.76% 6.3% 7.93% 7.08% 6.57%
CAPEX / EBITDA (%) 15.65% 23.99% 25.73% 28.42% 31.86% 38.69% 33.24% 29.83%
CAPEX / FCF (%) 34.96% 117.99% 101.98% 64.98% 86.4% 138.77% 95.74% 76.27%

Items per share

        
Cash flow per share 1 15.38 11.71 14.06 24.37 23.73 30.38 32.9 36.17
Change - -23.86% 20.09% 73.31% -2.61% 28.02% 8.29% 9.94%
Dividend per Share 1 1.25 1.32 1.32 1.45 1.45 1.724 2.041 2.382
Change - 5.6% 0% 9.85% 0% 18.88% 18.42% 16.68%
Book Value Per Share 1 85.82 99.42 107.6 124.6 134.3 153.6 174 199.4
Change - 15.85% 8.2% 15.79% 7.83% 14.39% 13.28% 14.57%
EPS 1 13.4 14.43 14.38 17.34 18 20.62 22.97 25.24
Change - 7.69% -0.35% 20.58% 3.81% 14.54% 11.4% 9.88%
Nbr of stocks (in thousands) 8,443 8,451 8,443 8,375 8,378 8,382 8,382 8,382
Announcement Date 3/22/22 A 3/23/23 A 3/19/24 A 3/13/25 A 3/17/26 A - - -
1EUR
Estimates
2026 *2027 *
P/E 15.4x 13.8x
PBR 2.07x 1.83x
EV / Sales 1.8x 1.65x
Yield 0.54% 0.64%

EPS & Dividend

EPS & Dividend - Virbac


Y-o-Y evolution of P/E

Valuation ratios - P/E - Virbac
 

Year-on-year evolution of the Yield

Valuation ratios - Yield - Virbac
Trader
Investor
Global
Quality
ESG MSCI
AA
Ratings Surperformance© - Virbac
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
318.00EUR
Average target price
412.75EUR
Spread / Average Target
+29.80%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Virbac